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Objective: To analyze the outcome after surgery for critical limb ischemia (CLI) due to tibial artery occlusion in patients
with systemic scleroderma.
Methods: The medical records of scleroderma patients with CLI due to tibial artery occlusion were reviewed with respect
to demographic data and perioperative variables.
Results: Eight patients were identified at The University of Tokyo Hospital from 1991 to 2007. The underlying collagen
disease was progressive systemic scleroderma in 6 patients and CREST syndrome in 2 patients. The subjects were 1 man
and 7 women with a mean age of 68 years. While hypercoagulability including positive anticardiolipin antibodies was
found in only 1 patient, all patients were antinuclear antibody (ANA) positive and 6 of 8 patients had a high titer of
centromere-type ANA. Five underwent pedal artery bypass and 1 underwent distal peroneal artery bypass, while 2
underwent primary limb amputation. Although 1 patient with bypass had early graft occlusion (with subsequent
below-knee amputation), the other 5 patients with patent grafts quickly achieved pain relief and initial wound healing.
However, four of the five patent grafts developed graft occlusion several months after surgery, with severe intimal
thickening at the anastomosis. As a result, 2 of 6 patients with bypass (totally 4 of 8 patients) underwent limb loss and
1 patient developed persistent recurrent ulcer.
Conclusion: Bypass surgery in patients with scleroderma and CLI can be successful in achieving early pain relief and
ischemic wound healing. However, the long-term effectiveness is limited with high rates of graft failure and limb loss.
(J Vasc Surg 2009;49:918-23.)While Raynaud’s phenomenon is the most common
vascular manifestation, digital ischemia is a predominant
complication of systemic scleroderma. Severely affected
patients develop vasculitis and/or thrombosis leading to
occlusion of digital arteries, and digital ulceration or
gangrene resulting in autoamputation of the digits. Re-
idy et al1 reported that only 7 of 1030 patients with
scleroderma developed non-healing ulcers which pro-
gressed in severity to require lower limb amputation,
while Hasegawa et al2 reported that arteriography could
identify stenosis or occlusion of tibial arteries at some
rate of patients with scleroderma and digital ulceration.
Obliteration of these vessels worsens ischemia and leads
to critical limb ischemia (CLI) of the lower extremity.3,4
Although a lesion of the infrapopliteal arteries in sclero-
derma can lead to major leg amputation, there have been
few reports on the management of CLI, including revas-
cularization. The present study describes systemic sclero-
derma patients with CLI who underwent pedal bypass
From the Division of Vascular Surgery, Department of Surgery,a and De-
partment of Pathology,b Graduate School of Medicine, The University of
Tokyo, Tokyo, Japan.
Competition of interest: none.
Reprint requests: Juno Deguchi, MD, The University of Tokyo School of
Medicine, Division of Vascular Surgery, Department of Surgery, 7-3-1
Hongo Bunkyo-ku, Tokyo 113-8655, Japan (e-mail: jdegu-tky@umin.
ac.jp).
0741-5214/$36.00
Copyright © 2009 by The Society for Vascular Surgery.
doi:10.1016/j.jvs.2008.10.066
918surgery and discusses the indication for bypass surgery in
those patients.
MATERIALS AND METHODS
This study reports a series of 8 patients (6 patients with
progressive systemic scleroderma [PSS] and 2 with its lim-
ited type CREST syndrome) who had CLI due to diffuse
infrapopliteal arterial occlusion, at the University of Tokyo
Hospital from 1991 to 2007.
Every patient enrolled in the study met the criteria for
scleroderma established by the American Rheumatism Asso-
ciation. Their medical records were checked and laboratory
tests were carried out. Immune serological tests comprised
antiphospholipid antibody, antineutrophil cytoplasmic anti-
body (ANCA, p-ANCA: perinuclear ANCA, c-ANCA: cyto-
plasmic ANCA), and antinuclear antibody (ANA). Measure-
ment of skin perfusion pressure by laser Doppler was described
previously.5 The tibial arteries are defined as infrapopliteal
arteries including the anterior and posterior tibial arteries,
peroneal artery, and their branches.
Patients underwent preoperative angiography to deter-
mine the precise targeted artery before bypass surgery. The
operative techniques are described briefly. Harvested vein
grafts were gently distended with heparinized autologous
blood under general anesthesia. The proximal anastomosis
was completed first, and all distal anastomoses were per-
formed under tourniquet ischemia without vascular clamps.
Native arteries were dissected and only the anterior surface of
the vascular sheath was exposed. During the anastomosis
procedure, activated coagulation time was maintained around
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After bypass surgery, all patients received continuous unfrac-
tionated heparin intravenously (10,000 or 12,000 U/day) for
the first 24 hours. Thereafter, all patients regularly received
oral antiplatelet agents (aspirin and ticlopidine).
Graft patency was confirmed by color Doppler echog-
raphy. When graft occlusion was suspected, patients under-
went angiography. Limb salvage was defined as preservation
of enough of the foot to allow ambulation and included feet
requiring a toe, or ray (finger amputation), or transmetatarsal
amputation after bypass surgery. Patients receiving Syme’s
amputation, or below- or above-knee amputation were
included in the limb loss criteria. Patients were followed at 1-
to 3-month intervals after discharge.
All patients, with severe or persistent rest pain received
counseling regarding the options of attempted limb salvage
or amputation and were allowed to make informed choices
regarding the direction of care. The Ethics Committee of
Tokyo University Hospital approved the surgery.
RESULTS
The underlying type of scleroderma comprised pro-
gressive systemic scleroderma in 6 patients and CREST
syndrome in 2. Demographic characteristics of the popula-
tion are shown in Table I. Seven patients were female and 1
was male, with a mean age of 68  10 years. The mean
disease duration from time of diagnosis was 13 months
(median, 10 months). Two of 8 patients had received
long-term steroid treatment. The mean follow-up period
after surgery (bypass or amputation) was 46 months (2-201
months, median, 33 months).
Preoperative data are shown in Table II. Skin perfusion
pressure (SPP) was very low near the area of gangrene.
ANCAs are antibodies against molecules playing a central
role in neutrophil and markers of vasculitis related to neu-
trophil (the antigen of p-ANCA and c-ANCA is myeloper-
oxidase and proteinase 3, respectively). Activated neutro-
phils bound with ANCAs cause endothelial cell damage in
vessels. Significant ANCA positivity (p-ANCA or c-ANCA)
was not observed in any patient during the development of
foot lesions. Antiphospholipid antibody is associated with
thrombosis in collagen disease patients. However, only
Table I. Patient characteristics
Gender Male 1, Female 7
Age (years) 67.8  10.4 (47  79)
Underlying scleroderma PSS: 6; CREST: 2
Duration of scleroderma at surgery
(years) 13  15 (1  48)
Long-term use of PSL 2 (2/8, 25.0%)
Risk factors for atherosclerosis
Hypertension 5 (5/8, 62.5%)
Diabetes mellitus 0 (0/8, 0%)
Hypercholesterelomia 0 (0/8, 0%)
Ex-smoker 2 (2/8, 25.0%)
PSS, Progressive systemic scleroderma; PSL, predonisolone.patient 7 was antiphospholipid antibody positive. She de-veloped acute thrombosis of the popliteal artery, and even-
tually underwent above-knee amputation because of acute
necrosis of the lower leg with concomitant infection. All
patients were ANA-positive and 6 had a high titer of ANA
with centromere pattern before surgery. Interestingly, clin-
ical symptoms other than foot lesions did not worsen in any
patient, while they showed a constantly high titer of ANA
with centromere pattern, which may reflect organ impair-
ment due to scleroderma. Although 5 of 6 patients under-
went regular tests for lung surfactant protein D (SP-D) and
sialylated carbohydrate antigen (KL-6), markers of respira-
tory status in scleroderma, no positive test was observed
during the follow-up of foot lesions (Table II). These
results suggest that a high titer of ANA (centromere pat-
tern) may relate to the development of foot ulcers or
gangrene in scleroderma.
Fig 1,A shows the preoperative angiogram of patient 1,
showing collaterals from the peroneal artery which col-
lected the blood flow to the posterior artery at the ankle
level. Preoperative angiography in patient 2 revealed an
almost normal popliteal artery, whereas both the anterior
and posterior tibial arteries were occluded proximally, and
the peroneal artery was disrupted in the middle (Fig 1, B).
All patients had occlusions in the anterior and posterior
tibial arteries and the peroneal artery.
Although all 8 patients were scheduled to undergo
revascularization, only 6 patients (patient 1 to 6) under-
went bypass surgery and the other 2 (patients 7 and 8)
underwent primary lower limb amputation (Table III). The
reasons for primary amputation were lack of an appropriate
autogenous vein and concomitant lower leg infection, re-
spectively. Eventually, necrosis with infection extended
above the ankle in both patients. Five patients underwent
pedal artery bypass and 1 received distal peroneal artery
bypass, using reversed autonomous great saphenous vein.
The inflow artery was the distal popliteal artery in 5 patients
and superficial femoral artery in 1 patient. The targeted
artery was the posterior tibial artery at the ankle level in 2
patients, the common plantar artery in 1 patient, the pero-
neal artery in 1 patient and the dorsalis pedis artery in 2
patients. Patient 1 underwent sequential bypass from the
popliteal to the peroneal to the posterior tibial artery.
The results of surgery are also listed in Table III. None
of the patients died from surgical complication in the
perioperative period. However, 1 patient who underwent
primary above-knee amputation because of sepsis, could
not overcome sepsis and died 2 months later (patient 7).
None of the patients experienced major operative compli-
cations such as myocardial or brain infarction or pneumonia
except 1 patient with wound infection (patient 6). One
graft occluded 3 days after bypass and another four grafts
failed within 2 years, while the other graft is still patent 6
months after surgery. During the follow-up period, a du-
plex echography scan detected a failing graft in 3 patients
(patients 1, 2, and 4 in Table III). We performed an
endovascular intervention in 1 patient, but the graft oc-
cluded 1 month after percutaneous transluminal angio-
plasty (PTA) (patient 2). Patient 4, with a failing graft,
CA, c
, spec
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vention. His graft occluded completely a couple of months
later. Patient 1, with a sequential bypass, who had stenosis
at the sequential anastomosis, underwent additional bypass
surgery from the distal popliteal to the graft. Then, a
stenosis of the distal (arrowhead) anastomosis at the first
bypass developed again, leading to a complete graft occlu-
sion 3 months later. In Fig 2, A, the angiogram of patient 1
shows sufficient blood flow without substantial intimal
narrowing 1 month after the first bypass surgery. However,
including a revision, the bypass graft resulted in total oc-
clusion in the course of 17 months. Eventually, 5 out of 6
patients had graft occlusion within 1 and 1/2 years. Only
patient 6 has a patent graft 6 months after bypass surgery.
Table III shows the status of wound healing and limb
salvage. Patient 3 with graft occlusion 3 days after bypass
surgery underwent below-knee amputation without wound
healing. Revascularization achieved ulcer healing and pain
relief in the other 5 patients (patients 1, 2, 4, 5, and 6). All
patients with graft occlusion after initial wound healing (pa-
tients 1, 2, 4, and 5) had a ‘subcritical ischemic leg’. Patients 2
and 5 achieved wound healing with toe amputation during
patency of the bypass graft followed by an ulcer-free course
even after graft occlusion, whereas patients 1 and 4 developed
a new ulcer or gangrene after graft failure. Of those, patient 1
had a severe ischemic leg with calf muscle necrosis and under-
went above-knee amputation 8 months after the graft occlu-
sion. On the other hand, patient 4 has not showed any sign of
further deterioration of his new ulcer for over 8 months. He
refused to undergo major amputation and dealt with the pain
using NSAIDs. Four out of 8 patients, including 2 who
underwent primary major limb amputation, lost their leg.
Histologic examinations revealed irregular fibrosis of
the artery at the proximal anastomosis from the amputated
Table II. Preoperative data of patients
Patient
no.
Age/
gender
Type of
scleroderma Duration
SPP
(mm Hg)
PSL
(mg  year)
1 62/F CREST 10 0 —
40
2 78/F PSS 1 20 —
35
3 69/F PSS 12 20 15  12
4 63/M CREST 1 20 —
60
5 47/F PSS 20 —
6 71/F PSS 20 10 —
7 73/F PSS 48 NA 10  2
8 79/F PSS 4 0 —
Numbers in parentheses are standard values. Duration indicates disease du
postoperative skin perfusion pressure (SPP, mm Hg) was measured near
Betamethasone was administered in 1 patient and was recalculated to the dos
antibody; ANA, antinuclear antibody; SP-D, lung surfactant protein D;
pressure; p-ANCA, perinuclear antineutrophil cytoplasmic antibody; c-AN
scleroderma; homo, homogeneous pattern; centro, centromere pattern; specklimb of patient 1 (Fig 2, B and C). Intimal thickeningcontained myxoid change, associated with accumulation of
spotty macrophages and smooth muscle cells (Fig 2, D).
Moderate intimal thickening also caused narrowing of the
arterial lumen at the distal anastomosis (Fig 2, E).
DISCUSSION
Patients with systemic scleroderma are predisposed to
developing a variety of leg ulcers and gangrene. Vasculitis
and/or thrombosis of digital arteries due to scleroderma
are involved in this painful complication. Deformity of
fingers is thought to worsen local ischemia. However,
Hafner et al6 reported that patients with scleroderma ex-
hibited multiple etiological features of ulcers including
venous and arterial factors and that atherosclerosis of the
superficial femoral artery worsens ulcers and gangrene. On
the other hand, Hasegawa et al2 reported that vascular
occlusion frequently occur within digital arteries and some-
times extends to tibial arteries in patients with digital ulcers
or gangrene. Dorevitch et al3 reported cases of lower limb
amputation secondary to large vessel involvement in sclero-
derma. The present study, therefore, focused on patients
with an ischemic leg ulcer or gangrene due to infrapopliteal
artery occlusion. Involvement of the tibial arteries can cause
harder-to-cure CLI inevitably necessitating major amputa-
tion.
The etiological mechanism of tibial arterial lesions re-
mains unclear. Herrick et al7 reported that mild vasculitis
occurred in some patients with digital ischemia requiring
amputation. Goldberger et al8 suggested those patients
with vasculitis were associated with antiphospholipid anti-
body (APA), a major factor of thrombosis in collagen
disease. On the other hand, positive ANCAs (p-ANCA or
c-ANCA) appear to be involved in inflammation including
local vasculitis. However, Hafner et al6 did not detect
A
.5)
p-ANCA
(10 U/l)
c-ANCA
(10 U/l) ANA (1:10)
SP-D
(110
ng/mL)
KI-6
(500
U/mL)
7 — — 1:2560 (centro) 44 425
7 — — 1:2560 (centro) 110 202
7 — — 1:2560 (centro) NA NA
2 — — 1:2560 (centro) 60 400
1 — — 1:2560 (speck)
1:320 (homo)
59 304
2 — — 1:40 (centro) 270 587
3 — — 1:2560 (centro) NA NA
7 — — 1:40 (centro)
1:320 (speck)
97 106
from time of diagnosis until development of foot ulcer. Preoperative or
cer (preoperative SPP without asterisk, postoperative SPP with asterisk).
edonisolone according to the glucocorticoid effect. APA, Antiphospholipid
sialylated carbohydrate antigen; PSL, predonisolone; SPP, skin perfusion
ytoplasmic antineutrophil cytoplasmic antibody; PSS, progressive systemic
kled pattern; NA, not applicable.AP
(3
0.
0.
0.
1.
3.
1.
6.
0.
ration
an ul
e of pr
KI-6,positive ANCAs in their study. We also found negative APA
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nation of skin biopsies demonstrated mild vasculitis, while
amputation specimens revealed no or mild vasculitis (data
not shown). This study, therefore, failed to demonstrate
that tibial arterial occlusion resulted from vasculitis.
Wigley et al9 demonstrated that anti-centromere anti-
bodies were related to digit loss in patients with sclero-
derma and that scleroderma patients with a positive anti-
centromere antibody had an increased risk of major
peripheral vascular occlusive disease. Takahashi et al,10 on
the other hand, reported that non-scleroderma patients
with anti-centromere antibodies suffered toe gangrene with
scleroderma-like vascular damage, and suggested that anti-
centromere antibodies may cause vascular damage. The
present study showed strongly positive ANA with a centro-
mere pattern, which recognized almost the same antigen as
anti-centromere antibody. This strong antibody positivity
Fig 1. Preoperative arteriograms. A, Arteriography of the left leg
revealed multiple lesions of the tibial arteries in patient 1. The
superficial femoral and popliteal arteries were almost normal. B,
Arteriography of the right leg showed occlusion of all three tibial
arteries and development of collaterals in patient 2. Note the
smooth popliteal artery without significant atherosclerosis.may relate to vascular damage below the knee.Revascularization in scleroderma patients with CLI
may be associated with two problems. First, systemic
scleroderma is known to extend to occlusion of digital
vessels. Guiducci et al11 reported that scleroderma is char-
acterized by injury of the vascular wall and extensive dam-
age of microvessels, suggesting that revascularization does
not provide functional blood flow to ischemic tissue. Sec-
ond, Herrick et al7 found severe hyperplasia at sites of
thrombosis in scleroderma, suggesting that hyperactivity of
local cells lead to intimal thickening at anastomotic sites.
The former causes graft failure a few days after surgery and
the latter causes graft failure several months after surgery.
We experienced 1 patient with graft failure 3 days after
surgery and 4 patients with graft failure several months after
surgery, which resulted from extensive peripheral vessel occlu-
sion and intimal thickening at the anastomotic site, respec-
tively. The graft patency in this study contrasted with that in
patients with bypass surgery for Fontaine IV atherosclerosis as
we previous reported.12 Fifty-seven (65 limbs) Fontaine IV
atherosclerosis patients underwent bypass surgery to an ankle
artery from 1991 to 2000; primary patency was 83%, and
secondary patency was 93% at 2 years in those patients.12 We
applied the same criteria to patients in this study as well as
patients with atherosclerosis based on the preoperative arte-
riogram. Although we recognized a patent tibial artery which
was confirmed by preoperative angiography and targeted it in
this study, like we did in patients with atherosclerosis, it was
difficult to determine whether the targeted artery had enough
run-off in scleroderma patients who may have extensive le-
sions in the digital arteries. In addition to the targeted artery
with less inflammation, we confirmed that a patient should
have a sufficient length of autogenous saphenous vein without
infection around the ankle. When patients had tissue loss and
needed Lisfranc’ or higher amputation, we advised them to
undergo a primary amputation as opposed to a bypass. On the
other hand, this study showed that five of six cases of revascu-
larization resulted in initial ulcer healing. In spite of poor
long-term results of revascularization, even a temporary in-
crease in circulation at the ulcer by revascularization may
relieve pain and heal a refractory ulcer. In this study, the rate of
deterioration of lower limb circulation appeared to have been
accelerating for some time. When this rapid deterioration of
lower limb circulation was halted by bypass with healing of
amputated toes, patients might achieve stable circulation even
if the graft became occluded.
Dorevitch et al3 reported that 5 of 9 scleroderma
patients, who had symptomatic peripheral vascular disease,
came to lower limb amputation. Therefore, revasculariza-
tion together with careful foot management may be the
treatment of choice for scleroderma patients with CLI
before major amputation.
Whatever the status of ulceration or gangrene, preven-
tion of skin breakdown is most important. Because tissue
has poor blood flow, minor skin trauma or spontaneous
fissuring may progress to CLI. Bosentan,13 an antagonist of
the endothelin receptor, may be effective in prevention of
new ulcers in patients with scleroderma.
Pop,Below-knee popliteal artery; SF, superficial femoral artery;Per,peroneal artery;Tp,posterior tibial artery at the ankle;DP,dorsalis pedis artery;PL, common plantar artery;
O, successful limb salvage;X,major limb loss;, patient 4 with persistent foot ulcer; Pt. no., patient number; PSS, progressive systemic scleroderma; BK, below the knee.
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AP view of lower part of sequential bypass. It shows sequential pedal artery bypass (from proximal popliteal to peroneal
to posterior tibial artery at the ankle). Note neither anastomotic site showed substantial intimal thickening. Arrowhead
indicates the proximal anastomotic site of the graft. Arrow indicates the distal anastomotic site of the bypass. C, D, E,
F, Histological findings in amputated limb of patient 1. Histological examination of a transverse section shows severe
intimal thickening of the artery at the proximal anastomotic site (C, Elastica von Gieson, D, Hematoxylin and eosin
staining). E, High power field of D. Note myofibrous proliferation with myxoid change. F, Transverse section of distalTable III. Results after surgery
Pt.
no.
Age/
gender
Type of
scleroderma
Bypass surgery,
graft patency
Duration of
patency (month)
Limb
salvage
Prognosis, follow-up
period (months) Comment
1 62/F CREST Pop (BK)-Per-Tp
(sequential),
occlusion
6 X Alive/39 Achievement of initial ulcer
healing, but subsequent
development of new
ulcer and gangrene led
above knee amputation
2 78/F PSS Pop (BK)-Tp,
occlusion
5 O Alive/33 Cured with toe amputation
3 69/F PSS Pop (BK)-DP,
occlusion
0.1 X Alive/17 Early graft occlusion led
below knee amputation
4 63/M CREST Pop (BK)-DP,
occlusion
17  Alive/25 Achievement of initial ulcer
healing, but subsequent
development of new
ulcer
5 47/F PSS SF-Per, occlusion 11 O Alive/201 Cured with toe amputation
6 71/F PSS Pop (BK)-PL, patent 7 O Alive/7 Cured ulcer
7 73/F PSS Primary above-knee amputation without
bypass surgery
X Hospital death/2 Died of sepsis 2 months
after amputation
8 79/F PSS Primary above-knee amputation without
bypass surgery
X Died of cancer/45
The upper 6 patients underwent revascularization surgery, while the lower 2 underwent primary limb amputation. Both the inflow and a targeted artery are
described in Bypass Surgery.anastomotic site of the artery shows narrowing of the lumen with intimal thickening.
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develop CLI due to tibial artery occlusions have high rates
of limb loss. Because compromised skin integrity associated
with this connective tissue disorder predisposes patients to
ulcerations, comprehensive foot protection and care is a
critical part of any limb salvage attempt. Although tibial
level arterial reconstruction (ie, distal bypass) results in pain
relief and early wound healing, even meaningful patency
and limb salvage rates are poor.
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